24 results on '"Haas, Marion"'
Search Results
2. Sustainable and effective methods to increase long‐acting reversible contraception uptake from the ACCORd general practice trial
- Author
-
Taft, Angela, Watson, Cathy J., McCarthy, Edwina, Black, Kirsten I., Lucke, Jayne, McGeechan, Kevin, Haas, Marion, McNamee, Kathleen, Peipert, Jeffrey F., and Mazza, Danielle
- Published
- 2022
- Full Text
- View/download PDF
3. Key considerations in reimbursement decision-making for multiple sclerosis drugs in Australia
- Author
-
Phan, Yen Hoang Le, De Abreu Lourenco, Richard, Haas, Marion, and van der Linden, Naomi
- Published
- 2018
- Full Text
- View/download PDF
4. Cost-effectiveness of a Population-based Lifestyle Intervention to Promote Healthy Weight and Physical Activity in Non-attenders of Cardiac Rehabilitation
- Author
-
Cheng, Qinglu, Church, Jody, Haas, Marion, Goodall, Stephen, Sangster, Janice, and Furber, Susan
- Published
- 2016
- Full Text
- View/download PDF
5. A Comparison of the Cost-effectiveness of Two Pedometer-based Telephone Coaching Programs for People with Cardiac Disease
- Author
-
Sangster, Janice, Church, Jody, Haas, Marion, Furber, Susan, and Bauman, Adrian
- Published
- 2015
- Full Text
- View/download PDF
6. Factors that drive the gap in diabetes rates between Aboriginal and non‐Aboriginal people in non‐remote NSW
- Author
-
Reeve, Rebecca, Church, Jody, Haas, Marion, Bradford, Wylie, and Viney, Rosalie
- Published
- 2014
- Full Text
- View/download PDF
7. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study
- Author
-
Wilcken, Bridget, Haas, Marion, Joy, Pamela, Wiley, Veronica, Chaplin, Meredyth, Black, Carly, Fletcher, Janice, McGill, Jim, and Boneh, Avihu
- Subjects
Fatty acid desaturases -- Health aspects ,Fatty acid desaturases -- Research ,Mortality -- Australia ,Mortality -- Prevention ,Morbidity -- Prevention ,Nutrition disorders -- Diagnosis ,Nutritionally induced diseases -- Diagnosis ,Infants (Newborn) -- Medical examination ,Infants (Newborn) -- Usage - Published
- 2007
8. Using stated preference discrete choice modeling to evaluate health care programs
- Author
-
Hall, Jane, Viney, Rosalie, Haas, Marion, and Louviere, Jordan
- Subjects
Health care industry -- Management ,Regional medical programs ,Health care industry ,Company business management ,Business ,Business, general - Abstract
An overview of health program evaluation methods, and the rationale for the use of stated preference discrete choice modelling (SPDCM) techniques is provided. The use of SPDCM to deal with these issues is well accepted in marketing, transport, and environmental economics.
- Published
- 2004
9. The Cost-Effectiveness of Adjuvant Tamoxifen Treatment of Hormone Receptor–Positive Early Breast Cancer Among Premenopausal and Perimenopausal Ghanaian Women.
- Author
-
Addo, Rebecca, Haas, Marion, and Goodall, Stephen
- Abstract
Most breast cancer cases in Ghana occur in premenopausal and perimenopausal (PPM) women. This study evaluated the cost-effectiveness of tamoxifen compared with no tamoxifen for the adjuvant treatment of hormone receptor–positive (HR+) early breast cancer (EBC) among PPM Ghanaian women. A Markov model was constructed to synthesize data on the effectiveness, costs, and health benefits of tamoxifen. Effectiveness and utility data were sourced from a literature review. Resource use and healthcare costs were estimated from Ghanaian sources. The evaluation was conducted in 2017 from the perspective of the health system over a 15-year time horizon. The financial impact of funding tamoxifen on Ghana's National Health Insurance Scheme (NHIS) was also estimated. Adjuvant tamoxifen treatment for women with HR+ EBC was more effective and more costly than no-tamoxifen therapy. The incremental benefit and costs were estimated to be 1.38 quality-adjusted life-years gained and Ghana cedis (GHC) 2338 ($520), respectively. The incremental cost-effectiveness ratio was estimated to be GHC 1694 ($376). The model was sensitive to the cost of tamoxifen and utility values. The cost of tamoxifen for the treatment of HR+ EBC represents less than 0.01% GHC 96 960 ($21 547) of the current NHIS total claims expenditure. Tamoxifen provides additional benefits to PPM Ghanaian women with HR+ EBC and is cost-effective compared with no tamoxifen. These results support the public funding of tamoxifen under the NHIS and provide Ghanaian policy makers with vital information for future budgetary planning. • Tamoxifen, an old off-patent drug has been established as cost-effective for the adjuvant treatment of breast cancer in postmenopausal women in high-income countries. • The findings from this article demonstrate that tamoxifen remains effective for the adjuvant treatment of breast cancer and in a low-to-middle-income country. Tamoxifen offers additional benefits to premenopausal and perimenopausal Ghanaian women with early breast cancer at an additional cost compared with no tamoxifen. • The findings from this study support the public funding of tamoxifen under the Ghana National Health Insurance Scheme. It provides decision makers with vital information for future budgetary planning. Other health systems with similar characteristics as Ghana could use the results of this study to inform funding decisions for tamoxifen for the adjuvant treatment of early breast cancer in premenopausal and perimenopausal women. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Corrigendum to ‘A Comparison of the Cost-effectiveness of two Pedometer-based Telephone Coaching Programs for People with Cardiac Disease’: [Heart, Lung and Circulation (2015) 24, 471–479]
- Author
-
Sangster, Janice, Church, Jody, Haas, Marion, Furber, Susan, and Bauman, Adrian
- Published
- 2016
- Full Text
- View/download PDF
11. Decisions about Pap tests: What influences women and providers?
- Author
-
Fiebig, Denzil G., Haas, Marion, Hossain, Ishrat, Street, Deborah J., and Viney, Rosalie
- Subjects
- *
PAP test , *CANCER diagnosis , *EXFOLIATIVE cytology , *CERVICAL cancer diagnosis , *MEDICAL screening , *HEALTH risk assessment , *HEALTH behavior - Abstract
Despite the success internationally of cervical screening programs debate continues about optimal program design. This includes increasing participation rates among under-screened women, reducing unnecessary early re-screening, improving accuracy of and confidence in screening tests, and determining the cost-effectiveness of program parameters, such as type of screening test, screening interval and target group. For all these issues, information about consumer and provider preferences and insight into the potential impact of any change to program design on consumer and provider behaviour are essential inputs into evidence-based health policy decision making. This paper reports the results of discrete choice experiments to investigate women's choices and providers'' recommendations in relation to cervical screening in Australia. Separate experiments were conducted with women and general practitioners, with attributes selected to allow for investigation of how women and general practitioners differ in their preferences for attributes of screening programs. Our results indicate a considerable commonality in preferences but the alignment was not complete. Women put relatively more weight on cost, chance of a false positive and if the recommended screening interval were changed to one year. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
12. Healthcare Use and Costs of Medium-chain Acyl-Coa Dehydrogenase Deficiency in Australia: Screening Versus No Screening.
- Author
-
Haas, Marion, Chaplin, Meredyth, Joy, Pamela, Wiley, Veronica, Black, Carly, and Wilcken, Bridget
- Abstract
Objective: To describe and analyze the use and costs of hospital services for children diagnosed with medium-chain acyl-CoA dehydrogenase (MCAD) deficiency either with newborn screening or clinical diagnosis in Australia between 1994 and 2002. MCAD deficiency is a potentially lethal disorder of fatty-acid oxidation. Study design: We conducted a retrospective audit of medical records supplemented by a parental survey. Results: A total of 59 children with MCAD deficiency were identified, 24 by using newborn screening. In the first 4 years of life, screening children cost an average of $A1676 (US$1297) per year for inpatient, emergency department, and outpatient visits, compared with $A1796 (US$1390) for children in whom a clinical diagnosis was made. Forty-two percent of the children who underwent screening were admitted to the hospital, compared with 71% of children who did not undergo screening. Children who did not undergo screening used significantly more inpatient services and cost significantly more in emergency services. There were also some significant differences in use on a year-by-year basis. Conclusions: Children who do not undergo screening may be more likely to be admitted to the hospital and to incur higher emergency department costs than children who underwent screening, and children seem more likely to attend hospital outpatient clinics. Screening does not result in higher costs from a hospital perspective. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
13. Increasing long-acting reversible contraceptives: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial.
- Author
-
Mazza, Danielle, Watson, Cathy J., Taft, Angela, Lucke, Jayne, McGeechan, Kevin, Haas, Marion, McNamee, Kathleen, Peipert, Jeffrey F., and Black, Kirsten I.
- Subjects
LONG-acting reversible contraceptives ,POSTPARTUM contraception ,CLUSTER randomized controlled trials ,LEVONORGESTREL intrauterine contraceptives ,GENERALIZED estimating equations ,FAMILY medicine ,FAMILY planning ,COUNSELING ,INTRAUTERINE contraceptives ,LEVONORGESTREL ,MEDICAL referrals ,ALTERNATIVE education - Abstract
Background: Long-active reversible contraceptives reduce unintended pregnancy and abortions, but uptake is low. Interventions to increase uptake in family medicine settings are untested.Objective: The Australian Contraceptive ChOice pRoject, which was adapted from the successful US Contraceptive CHOICE study, aimed to evaluate whether a complex intervention in family medicine practices resulted in increased long-active reversible contraceptive uptake.Study Design: This cluster randomized controlled trial was set in family practices in metropolitan Melbourne, Australia. From April 2016 to January 2017, we recruited 57 family physicians by mail invitation. Each family physician aimed to recruit at least 14 female patients. Eligible family physicians worked ≥3 sessions per week in computerized practices. Eligible women were English-speaking, sexually active, not pregnant, not planning a pregnancy in the next year, 16-45 years old, and interested in discussing contraception or in starting a new, reversible method. With the use of a randomization sequence with permuted blocks that were stratified by whether the family physician performed long-active reversible contraceptive insertion or not, family physicians were assigned randomly to a complex intervention that involved training to provide structured effectiveness-based contraceptive counselling and access to rapid referral to long-active reversible contraceptive insertion clinics. The 6-hour, online educational intervention was based on the US Contraceptive CHOICE Project and adapted for the Australian context. The control family physicians received neither the educational intervention nor access to the long-active reversible contraceptive rapid referral clinics and conducted their usual contraception counselling. We used the chi-square test, which was adjusted for clustering and stratification by whether the family physician inserted long-active reversible contraceptives, and binary regression models with generalized estimating equations and robust standard errors to compare, between the intervention and control groups, the proportions of women who had a long-active reversible contraceptive inserted. The primary outcome was the proportion of women with long-active reversible contraceptives that were inserted at 4 weeks. Secondary outcomes included women's choice of contraceptive method, quality of life, and long-active reversible contraceptive use at 6 and 12 months. Analyses were performed according to intention-to-treat.Results: A total of 25 intervention and 32 control family physicians recruited 307 and 433 women, respectively (N=740). Within 4 weeks, 19.3% of women in the intervention group and 12.9% of women in the control group had long-active reversible contraceptive inserted (relative risk, 2.0; 95% confidence interval, 1.1-3.9; P=.033). By 6 months, this number had risen to 44.4% and 29.3%, respectively (relative risk, 1.6; 95% confidence interval, 1.2-2.17; P=.001); by 12 months, it had risen to 46.6% and 32.8%, respectively (relative risk, 1.5; 95% confidence interval, 1.2-2.0; P=.0015). The levonorgestrel intrauterine system was the most commonly chosen long-active reversible contraceptive by women in the intervention group at all time points. Differences between intervention and control groups in mean quality-of-life scores across all domains at 6 and 12 months were small.Conclusion: A complex intervention combination of family physician training on contraceptive effectiveness counselling and rapid access to long-active reversible contraceptive insertion clinics resulted in greater long-active reversible contraceptive uptake and has the potential to reduce unintended pregnancies. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
14. Identification of cryptic Candida species by MALDI-TOF mass spectrometry, not all MALDI-TOF systems are the same: focus on the C. parapsilosis species complex.
- Author
-
Haas, Marion, Grenouillet, Frederic, Loubersac, Sophie, Ariza, Beatriz, Pepin-Puget, Line, Alvarez-Moreno, Carlos Arturo, Valderrama-Beltrán, Sandra Liliana, Lavergne, Rose-Anne, Le Pape, Patrice, and Morio, Florent
- Subjects
- *
MATRIX-assisted laser desorption-ionization , *BACTERIAL typing , *TIME-of-flight spectroscopy , *CANDIDA , *MICROBIOLOGISTS - Abstract
Data about the performance of MALDI-TOF mass spectrometry against cryptic Candida species are limited. According to our findings within the C. parapsilosis species complex, microbiologists should be aware that the choice of the instrument is critical for accurate species identification due to the risk of misidentification in the clinical setting. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
15. Cost-Effectiveness of Single Versus Multifraction SABR for Pulmonary Oligometastases: The SAFRON II Trial.
- Author
-
Lourenco, Richard De Abreu, Khoo, Terence, Crothers, Anna, Haas, Marion, Montgomery, Rebecca, Ball, David, Bressel, Mathias, and Siva, Shankar
- Subjects
- *
STEREOTACTIC radiotherapy , *COST effectiveness , *MEDICAL care use , *QUALITY of life , *AUSTRALIAN dollar , *ONCOLOGISTS - Abstract
Purpose: The use of stereotactic ablative body radiation therapy (SABR) in advanced cancer care is increasing, yet the cost-effectiveness of single-fraction (SF) versus multifraction (MF) SABR in pulmonary oligometastases is unknown.Methods: A prespecified cost-effectiveness analysis was conducted of the Trans Tasman Radiation Oncology Group 13.01 - SAFRON II - randomized trial comparing SF with MF SABR in 87 patients with 133 pulmonary oligometastases. A partitioned survival model assessed costs and quality-adjusted life-years (QALY) over the within-trial period (4 years) and longer-term (10 years). Costs reflected a societal perspective, expressed in Australian dollars (A$) using 2020 prices and were estimated using patient level data on health care utilization for radiation therapy (including patient time), post-radiation systemic therapy and treatment of adverse effects. Quality of life was assessed using the EuroQoL EQ-5D-5L. The incremental cost-effectiveness ratio (ICER) was expressed as the cost per QALY gained for SF versus MF SABR, with uncertainty assessed using deterministic and probabilistic sensitivity analyses.Results: SF cost less than MF for initial therapy (difference of A$1194/patient). Mean time to initiation of systemic drug therapy did not differ between arms (P = .94). Numerical differences in survival favoring SF resulted in greater overall health care use for the within-trial period. The within-trial ICER was A$15,821/QALY and A$23,265/QALY over the longer term. Results were most sensitive to the cost of postprogression therapies and utility values. The sensitivity analysis indicated that SF SABR has a 97% probability of being cost-effective at a willingness-to-pay of A$50,000/QALY.Conclusions: SF has lower initial costs and is highly likely to be cost-effective. Time to initiation of systemic therapy associated with disease progression is highly patient relevant and is a major driver of cost-effectiveness. Comparisons for SF SABR with nonradiation therapy approaches to the treatment of pulmonary oligometastases warrant further investigation. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
16. Taking a count: the evaluation of genetic testing
- Author
-
Hall, Jane, Viney, Rosalie, and Haas, Marion
- Published
- 1998
- Full Text
- View/download PDF
17. The potential benefits and harms of screening for colorectal cancer
- Author
-
Towler, Bernie, Irwig, Les, Glasziou, Paul, Haas, Marion, Plunkett, Angela, and Salkeld, Glenn
- Published
- 1995
- Full Text
- View/download PDF
18. Cost‐effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia
- Author
-
Salkeld, Glenn, Young, Graeme, Irwig, Les, Haas, Marion, and Glasziou, Paul
- Published
- 1996
- Full Text
- View/download PDF
19. The knowledge and attitude of Ghanaian decision-makers and researchers towards health technology assessment.
- Author
-
Addo, Rebecca, Hall, Jane, Haas, Marion, and Goodall, Stephen
- Subjects
- *
ATTITUDE (Psychology) , *COST effectiveness , *DECISION making , *INTERVIEWING , *MEDICAL personnel , *MEDICAL technology , *PRACTICAL politics , *PROFESSIONAL ethics , *PROFESSIONS , *QUALITY assurance , *SOCIAL boundaries , *THEMATIC analysis , *PSYCHOLOGY of Research personnel , *MIDDLE-income countries , *LOW-income countries , *STAKEHOLDER analysis - Abstract
Although health technology assessment (HTA) is intended to provide policymakers with objective information, the likelihood that a health decision-maker (HDM) will use this information is associated with their knowledge, role and perception of the HTA process. In Ghana, policymakers are working towards formalising the use of HTA, but HDM knowledge of and attitude towards HTA are not known. Between March and May 2016, we conducted in-depth interviews and used inductive thematic analysis to explore Ghanaian HDMs (n = 23) and researchers' (n = 4) perceptions of and barriers to HTA and identify ways to promote HTA. We compare our findings with those reported in previous studies conducted in low-and-middle-income countries. Common themes were that resources, political and cultural factors act as barriers to HTA use. Recommendations made in previous studies which were also identified in this study included the need for the development of both human and data capacity, allocating funds to HTA and stakeholder involvement in HTA processes. Specific recommendations made by Ghanaian HDMs and researchers in this study focused on the establishment of an HTA body: its location, the constitution of the appraisal team, the type of evidence to appraise and who makes the final decision. The findings provide important information in the context of current planning to institutionalise HTA in Ghana. Addressing the identified barriers will enable policymakers to maximise the chances of realising the expected benefits of HTA, as participants who are potential producers and end-users are likely to use what they have contributed to. • As with other LMIC, decision-makers in Ghana have limited knowledge about HTA. • The identified barriers to HTA were resources, political and cultural issues. • To promote the use of HTA the identified barriers need addressing. • Decision-makers were positive about implementing HTA and identified areas of use. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
20. Association of processes of primary care and hospitalisation for people with diabetes: A record linkage study.
- Author
-
Comino, Elizabeth Jean, Islam, MD Fakhrul, Tran, Duong Thuy, Jorm, Louisa, Flack, Jeff, Jalaludin, Bin, Haas, Marion, and Harris, Mark Fort
- Subjects
- *
TREATMENT of diabetes , *PEOPLE with diabetes , *PRIMARY health care , *HOSPITAL care , *DISEASE incidence - Abstract
Aims To explore the association of primary care and hospitalisation for people with diabetes. Methods The study comprised 20,433 diabetic participants in the Sax Institute's 45 and Up Study. Data on processes of care at recruitment (15 months) were extracted from the Department of Human Services Medicare database. Processes included continuity of primary care (47.1%), and claims for completion of an annual cycle of care (25.0%), GP management plan/team care arrangement (GPMP/TCA, 41.3%), review of GPMP/TCA (24.0%), and monitoring including HbA1c (62.7%). Hospitalisation (12 months) following recruitment was extracted from administrative data held by NSW Ministry of Health. Adjusted incidence rate ratios (aIRR) with 95% confidence interval were calculated. Results A hospital admission was reported for 33.0% of participants. Continuity of care (aIRR: 0.92 (95%CI: 0.89–0.96)), or claims for an annual cycle of care (aIRR: 0.77 (0.74–0.80)) or HbA1c testing (aIRR: 0.92 (0.89–0.96) were associated with a reduced likelihood of hospitalisation. While claims for preparation of GPMP/TCA were not associated with hospitalisation, a claim for review of GPMP/TCA was associated with a reduced likelihood of hospitalisation (aIRR: 0.92 (95%CI: 0.89 0.96)). Conclusions This study has implications for hospital avoidance programmes suggesting that strengthening primary care may be more important than care coordination for this group of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
21. The effect of adverse information and positive promotion on women's preferences for prescribed contraceptive products
- Author
-
Knox, Stephanie A., Viney, Rosalie C., Gu, Yuanyuan, Hole, Arne R., Fiebig, Denzil G., Street, Deborah J., Haas, Marion R., Weisberg, Edith, and Bateson, Deborah
- Subjects
- *
PATIENTS , *DECISION making , *CONTRACEPTIVE drugs , *DESCRIPTIVE statistics - Abstract
Abstract: Recent rapid growth in the range of contraceptive products has given women more choice, but also adds complexity to the resultant decision of which product to choose. This paper uses a discrete choice experiment (DCE) to investigate the effect of adverse information and positive promotion on women''s stated preferences for prescribed contraceptive products. In November 2007, 527 Australian women aged 18–49 years were recruited from an online panel. Each was randomly allocated to one of three information conditions. The control group only received basic information on contraceptive products. One treatment group also received adverse information on the risks of the combined oral pill. The other group received basic information and promotional material on the vaginal ring, newly introduced into Australia and on the transdermal patch, which is unavailable in Australia. Respondents completed 32 choice sets with 3 product options where each option was described by a product label: either combined pill, minipill, injection, implant, hormonal IUD, hormonal vaginal ring, hormonal transdermal patch or copper IUD; and by the attributes: effect on acne, effect on weight, frequency of administration, contraceptive effectiveness, doctor''s recommendation, effect on periods and cost. Women''s choices were analysed using a generalized multinomial logit model (G-MNL) and model estimates were used to predict product shares for each information condition. The predictions indicated that adverse information did not affect women''s preferences for products relative to only receiving basic information. The promotional material increased women''s preferences for the transdermal patch. Women in all groups had a low preference for the vaginal ring which was not improved by promotion. The findings highlight the need for researchers to pay attention to setting the context when conducting DCEs as this can significantly affect results. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
22. Staff outcomes from the Caring for Aged Dementia Care REsident Study (CADRES): A cluster randomised trial
- Author
-
Jeon, Yun-Hee, Luscombe, Georgina, Chenoweth, Lynn, Stein-Parbury, Jane, Brodaty, Henry, King, Madeleine, and Haas, Marion
- Subjects
- *
JOB stress prevention , *AGE distribution , *ANALYSIS of variance , *CHI-squared test , *CLINICAL trials , *DEMENTIA , *EMPLOYEES , *EXPERIENCE , *GERIATRIC nursing , *MEDICAL quality control , *MEDICAL protocols , *MULTIVARIATE analysis , *NURSES , *NURSES' attitudes , *NURSES' aides , *NURSING care facilities , *SCIENTIFIC observation , *PERSONNEL management , *PRACTICAL nurses , *QUESTIONNAIRES , *RESEARCH funding , *STATISTICS , *JUDGMENT sampling , *DATA analysis , *EFFECT sizes (Statistics) , *RANDOMIZED controlled trials , *REPEATED measures design , *PATIENT-centered care , *DESCRIPTIVE statistics - Abstract
Abstract: Background: Dementia care mapping and person centred care are well-accepted as processes for improving care and well-being for persons with dementia living in the residential setting. However, the impact of dementia care mapping and person centred care on staff has not been well researched. Objectives: The impact of person centred care and dementia care mapping compared to each other and to usual dementia care on staff outcomes was examined in terms of staff burnout, general well-being, attitudes and reactions towards resident behavioural disturbances, perceived managerial support, and quality of care interactions. Design: A cluster-randomised, controlled trial. Settings: The study was conducted between 2005 and 2007 in 15 residential aged care sites in the Sydney metropolitan area, Australia, with comparable management structures, staffing mix and ratios, and standards of care. Participants: 194 consenting managers, nurses, therapists and nurse assistants working in the participating sites. Methods: Intervention care sites received training and support in either person centred care (n =5) or dementia care mapping (n =5); control sites continued with usual dementia care (n =5). Staff outcomes of those three groups were assessed before, directly after the four month intervention (post) and after a further four months (follow-up). The primary outcome measures were the Maslach Burnout Inventory-Human Services Survey and the 12-item General Health Questionnaire. Analysis involved repeated measures analyses of variance for each of the outcome measures and adjustment for potential confounders to limit bias. Results: The Maslach Burnout Inventory-Human Services Survey results showed that change over time in emotional exhaustion scores differed between the three groups. Post-hoc analyses for each group separately revealed that the only significant time effect was in the dementia care mapping group (p =0.006), with emotional exhaustion scores declining over time. At baseline, more perceived support from management was associated with less emotional exhaustion (r s =0.26, p =0.004, n =122) and less depersonalisation (r s =0.21, p =0.023, n =122), but not for any of the other outcome measures. Conclusions: This study has shown that person centred approaches of care, in particular with dementia care mapping, may contribute to reducing staff job related burnout. The findings also highlight a potentially important role of managerial support and a whole of system approach. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
23. Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial
- Author
-
Chenoweth, Lynn, King, Madeleine T, Jeon, Yun-Hee, Brodaty, Henry, Stein-Parbury, Jane, Norman, Richard, Haas, Marion, and Luscombe, Georgina
- Subjects
- *
CARE of dementia patients , *TREATMENT of dementia , *AGE factors in disease , *HEALTH outcome assessment , *RANDOMIZED controlled trials , *QUALITY of life , *MULTILEVEL models , *MEDICAL centers - Abstract
Summary: Background: Evidence for improved outcomes for people with dementia through provision of person-centred care and dementia-care mapping is largely observational. We aimed to do a large, randomised comparison of person-centred care, dementia-care mapping, and usual care. Methods: In a cluster randomised controlled trial, urban residential sites were randomly assigned to person-centred care, dementia-care mapping, or usual care. Carers received training and support in either intervention or continued usual care. Treatment allocation was masked to assessors. The primary outcome was agitation measured with the Cohen-Mansfield agitation inventory (CMAI). Secondary outcomes included psychiatric symptoms including hallucinations, neuropsychological status, quality of life, falls, and cost of treatment. Outcome measures were assessed before and directly after 4 months of intervention, and at 4 months of follow-up. Hierarchical linear models were used to test treatment and time effects. Analysis was by intention to treat. This trial is registered with the Australia and New Zealand Clinical Trials Registry, number ACTRN12608000084381. Findings: 15 care sites with 289 residents were randomly assigned. Pairwise contrasts revealed that at follow-up, and relative to usual care, CMAI score was lower in sites providing mapping (mean difference 10·9, 95% CI 0·7–21·1; p=0·04) and person-centred care (13·6, 3·3–23·9; p=0·01). Compared with usual care, fewer falls were recorded in sites that used mapping (0·24, 0·08–0·40; p=0·02) but there were more falls with person-centred care (0·15, 0·02–0·28; p=0·03). There were no other significant effects. Interpretation: Person-centred care and dementia-care mapping both seem to reduce agitation in people with dementia in residential care. Funding: Australian Health Ministers'' Advisory Council. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
24. The rationing of health care: should Oregon be transported to Australia?
- Author
-
Hall, Jane and Haas, Marion
- Published
- 1992
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.